102 related articles for article (PubMed ID: 18694767)
21. Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk.
Ricks-Santi LJ; Sucheston LE; Yang Y; Freudenheim JL; Isaacs CJ; Schwartz MD; Dumitrescu RG; Marian C; Nie J; Vito D; Edge SB; Shields PG
BMC Cancer; 2011 Jun; 11():278. PubMed ID: 21708019
[TBL] [Abstract][Full Text] [Related]
22. Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling.
Moghadasi S; Hofland N; Wouts JN; Hogervorst FB; Wijnen JT; Vreeswijk MP; van Asperen CJ
J Med Genet; 2013 Feb; 50(2):74-9. PubMed ID: 23231788
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing.
Brandão RD; van Roozendaal K; Tserpelis D; Gómez García E; Blok MJ
Breast Cancer Res Treat; 2011 Oct; 129(3):971-82. PubMed ID: 21638052
[TBL] [Abstract][Full Text] [Related]
24. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
Sanz DJ; Acedo A; Infante M; Durán M; Pérez-Cabornero L; Esteban-Cardeñosa E; Lastra E; Pagani F; Miner C; Velasco EA
Clin Cancer Res; 2010 Mar; 16(6):1957-67. PubMed ID: 20215541
[TBL] [Abstract][Full Text] [Related]
25. Alternative splicing and molecular characterization of splice site variants: BRCA1 c.591C>T as a case study.
Dosil V; Tosar A; Cañadas C; Pérez-Segura P; Díaz-Rubio E; Caldés T; de la Hoya M
Clin Chem; 2010 Jan; 56(1):53-61. PubMed ID: 19892845
[TBL] [Abstract][Full Text] [Related]
26. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer.
Sehl ME; Langer LR; Papp JC; Kwan L; Seldon JL; Arellano G; Reiss J; Reed EF; Dandekar S; Korin Y; Sinsheimer JS; Zhang ZF; Ganz PA
Clin Cancer Res; 2009 Mar; 15(6):2192-203. PubMed ID: 19276285
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
Shattuck-Eidens D; Oliphant A; McClure M; McBride C; Gupte J; Rubano T; Pruss D; Tavtigian SV; Teng DH; Adey N; Staebell M; Gumpper K; Lundstrom R; Hulick M; Kelly M; Holmen J; Lingenfelter B; Manley S; Fujimura F; Luce M; Ward B; Cannon-Albright L; Steele L; Offit K; Thomas A
JAMA; 1997 Oct; 278(15):1242-50. PubMed ID: 9333265
[TBL] [Abstract][Full Text] [Related]
28. Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
Khan Y; Khan NU; Ali I; Khan S; Khan AU; Iqbal A; Adams BD
Mol Biol Rep; 2023 Jul; 50(7):6087-6096. PubMed ID: 37300745
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis Induction with Combined Use of Cisplatin and Fisetin in Cisplatin-Resistant Ovarian Cancer Cells (A2780).
Jafarzadeh S; Baharara J; Tehranipour M
Avicenna J Med Biotechnol; 2021; 13(4):176-182. PubMed ID: 34900143
[TBL] [Abstract][Full Text] [Related]
30. BRCA1 and BRCA2 mutations in a sample of breast and ovarian cancer families from the Colombian pacific.
Cifuentes-C L; Rivera-Herrera AL; Barreto G
Colomb Med (Cali); 2019 Sep; 50(3):163-175. PubMed ID: 32284662
[TBL] [Abstract][Full Text] [Related]
31. Screening, diagnosis and genetic study of breast cancer patients in Pakistan.
Majeed AI; Ullah A; Jadoon M; Ahmad W; Riazuddin S
Pak J Med Sci; 2020; 36(2):16-20. PubMed ID: 32063924
[TBL] [Abstract][Full Text] [Related]
32. Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis.
de Oliveira ES; Soares BL; Lemos S; Rosa RC; Rodrigues AN; Barbosa LA; de Oliveira Lopes D; dos Santos LL
Fam Cancer; 2016 Apr; 15(2):173-81. PubMed ID: 26666763
[TBL] [Abstract][Full Text] [Related]
33. Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer.
Nicolas E; Arora S; Zhou Y; Serebriiskii IG; Andrake MD; Handorf ED; Bodian DL; Vockley JG; Dunbrack RL; Ross EA; Egleston BL; Hall MJ; Golemis EA; Giri VN; Daly MB
Oncotarget; 2015 Nov; 6(37):39614-33. PubMed ID: 26485759
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.
Domagala P; Jakubowska A; Jaworska-Bieniek K; Kaczmarek K; Durda K; Kurlapska A; Cybulski C; Lubinski J
PLoS One; 2015; 10(6):e0130393. PubMed ID: 26083025
[TBL] [Abstract][Full Text] [Related]
35. MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis.
Danza K; De Summa S; Pinto R; Pilato B; Palumbo O; Merla G; Simone G; Tommasi S
Oncotarget; 2015 Jan; 6(1):471-83. PubMed ID: 25333258
[TBL] [Abstract][Full Text] [Related]
36. Invasive ductal carcinoma of the breast in a 14-year-old girl.
Kim JY; Kim YJ; Kim SH; Kang BJ; Song BJ
Pediatr Radiol; 2014 Nov; 44(11):1446-9. PubMed ID: 24997789
[TBL] [Abstract][Full Text] [Related]
37. Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer.
De Summa S; Pinto R; Pilato B; Sambiasi D; Porcelli L; Guida G; Mattioli E; Paradiso A; Merla G; Micale L; De Nittis P; Tommasi S
Cell Death Dis; 2014 Feb; 5(2):e1076. PubMed ID: 24556691
[TBL] [Abstract][Full Text] [Related]
38. Genetic risk transmission in a family affected by familial breast cancer.
Pilato B; De Summa S; Danza K; Lacalamita R; Lambo R; Sambiasi D; Paradiso A; Tommasi S
J Hum Genet; 2014 Jan; 59(1):51-3. PubMed ID: 24152768
[TBL] [Abstract][Full Text] [Related]
39. BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study.
Ricks-Santi LJ; Nie J; Marian C; Ochs-Balcom HM; Trevisan M; Edge SB; Kanaan Y; Freudenheim JL; Shields PG
Genet Epidemiol; 2013 Jul; 37(5):504-11. PubMed ID: 23674270
[TBL] [Abstract][Full Text] [Related]
40. DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer families.
Pilato B; De Summa S; Danza K; Papadimitriou S; Zaccagna P; Paradiso A; Tommasi S
Mol Biotechnol; 2012 Sep; 52(1):8-15. PubMed ID: 22072316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
